3D PREDICT
Dead / Abandoned — Abandoned — after ex parte appeal (as of 13 Feb 2024)
What this means for you
This application is over — abandoned 13 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90818228
- Mark type
- Stylized text
- Filed
- 08 Jul 2021
- Abandoned
- 13 Feb 2024
- Attorney of record
- KATHRYNN M LYDDANE
Goods and services
- Class 001 — Chemicals: Assays for clinical laboratory or research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents and assays for culturing cells for clinical laboratory or research use
- Class 005 — Pharmaceuticals: Assay kits comprising clinical medical reagents for culturing cells for clinical medical use
- Class 009 — Scientific and electric apparatus: Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling
- Class 010 — Medical apparatus: Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies
- Class 042 — Scientific and technological services: Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology
- Class 044 — Medical, beauty and agricultural services: Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies
Owner
- KIYATEC Inc., Greenville, SC, US
Prosecution history
- 14 Feb 2024 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 13 Feb 2024 — ABANDONMENT - AFTER EX PARTE APPEAL
- 13 Feb 2024 — EXPARTE APPEAL TERMINATED
- 03 Jan 2024 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 18 Oct 2023 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 18 Oct 2023 — ACTION DENYING REQ FOR RECON E-MAILED
- 18 Oct 2023 — ACTION CONTINUING FINAL - COMPLETED
- 18 Aug 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Aug 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Apr 2023 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 27 Apr 2023 — EX PARTE APPEAL-INSTITUTED
- 27 Apr 2023 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 27 Apr 2023 — EXPARTE APPEAL RECEIVED AT TTAB
- 28 Oct 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 28 Oct 2022 — FINAL REFUSAL E-MAILED